David Davies, LSW in Alpha, NJ - Social Worker

David Davies, LSW is a Social Worker - Clinical based in Alpha, New Jersey. David Davies is licensed to practice in * (Not Available) (license number ) and his current practice location is 708 Schley Ave, Alpha, New Jersey. He can be reached at his office (for appointments etc.) via phone at (908) 827-1873.

NPI number for David Davies is 1316658552 and his current mailing address is 128 S Adelaide Ave Apt 2b, Highland Park, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316658552.

Contact Information

	David Davies, LSW
	708 Schley Ave, Alpha, NJ 08865-4270
	(908) 827-1873
	Not Available

Healthcare Provider's Profile

Full Name	David Davies
Gender	Male
Speciality	Social Worker - Clinical
Location	708 Schley Ave, Alpha, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316658552
Provider Enumeration Date: 12/08/2022
Last Update Date: 12/08/2022

Medical Identifiers

Medical identifiers for David Davies such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316658552	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Davies is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Davies, LSW 128 S Adelaide Ave Apt 2b, Highland Park, NJ 08904-1650 Ph: () -	David Davies, LSW 708 Schley Ave, Alpha, NJ 08865-4270 Ph: (908) 827-1873

News Archive

Second annual CNS Summit to shape the future of drug development

Segal Institute for Clinical Research, a consortium of CNS and women's health research sites, is preparing to again be actively involved in CNS Summit this coming fall.

Advances in head and neck cancer treatments: an interview with Prof. Argiris

Patients with head and neck cancer usually present with locally advanced disease and often require more than one type of treatment, which may include surgery, radiotherapy, and chemotherapy.

Abiomed's Impella cVAD device awarded CE Mark

Abiomed, Inc., a leading provider of break-through heart support technologies, today announced it has received CE Marking approval in the European Union to market the Impella cVAD device, a new percutaneous Impella® heart pump that provides peak flow of approximately 4 liters of blood per minute.

Nine million free condoms given away in New York

The New York City Department of Health and Mental Hygiene over the past six months has distributed more than nine million condoms at no cost via a Web site as part of an initiative to curb the spread of HIV and other sexually transmitted infections, the New York Post reports.

Pro-Pharmaceuticals completes $6 million private placement with 10X Fund

Pro-Pharmaceuticals, Inc., today announced that it has closed the $570,000 final tranche to complete a $6 million private placement with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants.

David Davies, LSW - Clinical Social Worker in Alpha, NJ